The role of MIF/CD74 in lung metastasis of breast cancer and whether the combination of MIF inhibitors and AEP inhibitors is safer and more effective than the chemotherapy drug combination regimen used in previous studies (AEP inhibitors + epirubicin) are still unknown. The gene discussed is LGMN; the disease is breast carcinoma.